Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-25-004797
Filing Date
2025-06-13
Accepted
2025-06-13 16:15:27
Documents
1
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4187
  Complete submission text file 0001562180-25-004797.txt   5727
Mailing Address C/O ACELYRIN, INC. 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address
Dier Mardi (Reporting) CIK: 0001574591 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39527 | Film No.: 251046761

Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Issuer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)